Pamisell has ranked among the top searched stocks for 8 days in the past month.
As of 1:30 PM on the 18th, Pamisell is trading at 23,350 KRW, up 2.86% from the previous day. This marks a 45.03% increase compared to October 22. Pamisell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.
Today, foreigners are tentatively recorded as net buyers of 108,000 shares. Over the past 5 days, individual investors have net bought 50,758 shares, while foreigners and institutions have net sold 26,214 shares and net bought 3,587 shares, respectively.


※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
